Skip to content

Clinical trials

Phase 3 Heart Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20071
20082
20092
20101
20111
20131
20171
20182
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting4
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline2
Alexion Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Bayer1
CSL Behring1
Daiichi Sankyo1
Duke University1
Eidos Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases21
Cardiovascular Diseases9
Atherosclerosis5
Stroke5
Acute Coronary Syndrome4
Myocardial Infarction4
Coronary Artery Disease3
Heart Failure3
Peripheral Arterial Disease3
Renal Insufficiency, Chronic3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.